65
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Borderline HER‐2 breast cancer cases: Histochemical versus real‐time PCR analysis and impact of different cut‐off values

, , , , , , , & show all
Pages 402-412 | Received 07 Jun 2006, Accepted 17 Nov 2006, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesca Sanguedolce & Pantaleo Bufo. (2015) HER2 assessment by silver in situ hybridization: where are we now?. Expert Review of Molecular Diagnostics 15:3, pages 385-398.
Read now

Articles from other publishers (10)

Agata Szymiczek, Amna Lone & Mohammad R. Akbari. (2020) Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive review. Clinical Genetics 99:5, pages 613-637.
Crossref
Vincenzo Arena, Ilaria Pennacchia, Fabio M. Vecchio & Arnaldo Carbone. (2019) ER−/PR+/HER2− breast cancer type shows the highest proliferative activity among all other combined phenotypes and is more common in young patients: Experience with 6643 breast cancer cases. The Breast Journal 25:3, pages 381-385.
Crossref
Yiwei Tong, Xiaosong Chen, Xiaochun Fei, Lin Lin, Jiayi Wu, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li & Kunwei Shen. (2018) Can breast cancer patients with HER2 dual-equivocal tumours be managed as HER2-negative disease?. European Journal of Cancer 89, pages 9-18.
Crossref
Christopher B. Raub, Chen-Chung Lee, Darryl Shibata, Clive Taylor & Emil Kartalov. (2016) HistoMosaic Detecting KRAS G12V Mutation Across Colorectal Cancer Tissue Slices through in Situ PCR. Analytical Chemistry 88:5, pages 2792-2798.
Crossref
Ilaria Pennacchia, Fabio M. Vecchio, Arnaldo Carbone & Vincenzo Arena. (2015) HER2 Immunohistochemical Assessment With A0485 Polyclonal Antibody. Applied Immunohistochemistry & Molecular Morphology 23:1, pages 31-35.
Crossref
Antonio C. Wolff, M. Elizabeth H. Hammond, David G. Hicks, Mitch Dowsett, Lisa M. McShane, Kimberly H. Allison, Donald C. Allred, John M.S. Bartlett, Michael Bilous, Patrick Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Pamela B. Mangu, Soonmyung Paik, Edith A. Perez, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale & Daniel F. Hayes. (2014) Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Archives of Pathology & Laboratory Medicine 138:2, pages 241-256.
Crossref
Jocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni, Marie-Joëlle Mozziconacci, Martine Antoine, Laurent Arnould, Sarab Lizard, Philippe Bertheau, Jacqueline Lehmann-Che, Cécile Blanc Fournier, Sophie Krieger, Frédéric Bibeau, Pierre-Jean Lamy, Marie Pierre Chenard, Michèle Legrain, Jean-Marc Guinebretière, Delphine Loussouarn, Gaëtan MacGrogan, Isabelle Hostein, Marie Christine Mathieu, Ludovic Lacroix, Alexander Valent, Yves Marie Robin, Françoise Revillion, Magali Lacroix Triki, Aline Seaume, Anne Vincent Salomon, Patricia de Cremoux, Geneviève Portefaix, Luc Xerri, Sophie Vacher, Ivan Bièche & Frédérique Penault-Llorca. (2013) SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases. BMC Cancer 13:1.
Crossref
Antonio C. WolffM. Elizabeth H. HammondDavid G. HicksMitch DowsettLisa M. McShaneKimberly H. AllisonDonald C. AllredJohn M.S. BartlettMichael BilousPatrick FitzgibbonsWedad HannaRobert B. JenkinsPamela B. ManguSoonmyung PaikEdith A. PerezMichael F. PressPatricia A. SpearsGail H. VanceGiuseppe VialeDaniel F. Hayes. (2013) Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Journal of Clinical Oncology 31:31, pages 3997-4013.
Crossref
K Page, N Hava, B Ward, J Brown, D S Guttery, C Ruangpratheep, K Blighe, A Sharma, R A Walker, R C Coombes & J A Shaw. (2011) Detection of HER2 amplification in circulating free DNA in patients with breast cancer. British Journal of Cancer 104:8, pages 1342-1348.
Crossref
Vincenzo Arena, Ilaria Pennacchia, Giovanni Monego, Arnaldo Carbone & Arnaldo Capelli. (2010) Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies . Journal of Clinical Oncology 28:5, pages e83-e84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.